A Meta-analysis: Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD) Receiving PAH Medication

被引：0

作者：

Krasuski, R. A. ^{[1
]}

Tobore, T. ^{[2
]}

Studer, S. ^{[2
,3
]}

Jansa, P. ^{[4
,5
]}

Sitbon, O. ^{[6
]}

Hoeper, M. M. ^{[7
,8
]}

Channick, R. N. ^{[9
]}

Gaine, S. ^{[10
]}

Lang, I. M. ^{[11
,12
]}

Chin, K. M. ^{[13
]}

Pulido, T. ^{[14
]}

Mehta, S. ^{[15
]}

Torbicki, A. ^{[16
]}

Sastry, B. ^{[17
]}

Tang, X. ^{[2
]}

McLaughlin, V. ^{[18
]}

Reardon, L. ^{[19
]}

机构：

[1] Duke Univ Hlth Syst, Durham, NC USA

[2] Actel Pharmaceut US Inc, Titusville, NJ USA

[3] Johnson & Johnson, Janssen Pharmaceut Co, Titusville, NJ USA

[4] Charles Univ Prague, Prague, Czech Republic

[5] Gen Univ Hosp, Prague, Czech Republic

[6] Univ Paris Saclay, Hop Bicetre, AP HP, Le Kremlin Bicetre, France

[7] Hannover Med Sch, Hannover, Germany

[8] German Ctr Lung Res DZL, Hannover, Germany

[9] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA

[10] Mater Misericordiae Univ Hosp, Dublin, Ireland

[11] Med Univ Vienna, Cardiol, Vienna, Austria

[12] Med Univ Vienna, Ctr Cardiovasc Med, Vienna, Austria

[13] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX USA

[14] Natl Heart Inst, Mexico City, DF, Mexico

[15] Western Univ, Schulich Sch Med & Dent, London, ON, Canada

[16] ECZ Otwock, European Hlth Ctr, Ctr Postgrad Med Educ, Otwock, Poland

[17] CARE Hosp, Hyderabad, Telangana, India

[18] Univ Michigan Hlth Syst, Ann Arbor, MI USA

[19] Univ Calif Los Angeles, Ahmanson UCLA Adult Congenital Heart Dis Ctr, Los Angeles, CA USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A6460

引用

页数：2

共 50 条

[21] Treatment with macitentan for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD): real-world experience from the combined OPUS and OrPHeUS data sets
McLaughlin, V
Chin, K.
Kim, N. H.
Flynn, M.
Ong, R.
Wetherill, G.
Channick, R.
EUROPEAN HEART JOURNAL, 2020, 41 : 2293 - 2293
[22] Effects of pulmonary hypertension targeted therapy on haemodynamics in pulmonary arterial hypertension associated with adult congenital heart disease: a meta-analysis
Tsigkriki, L.
Ntiloudi, D.
Papanastasiou, C.
Varrias, D.
Giannakoulas, G.
EUROPEAN HEART JOURNAL, 2024, 45
[23] Effects of pulmonary hypertension targeted therapy on haemodynamics in pulmonary arterial hypertension associated with adult congenital heart disease: a meta-analysis
Tsigkriki, L.
Ntiloudi, D.
Papanastasiou, C.
Varrias, D.
Giannakoulas, G.
EUROPEAN HEART JOURNAL, 2024, 45
[24] Thyroid disease and pulmonary arterial hypertension (PAH) in patients treated with prostacyclin
Ferris, AM
Morse, JH
Jacobs, T
Rosenzweig, EB
Aranoff, GS
Barst, RJ
CIRCULATION, 2000, 102 (18) : 426 - 427
[25] High-risk pregnancy in a patient with pulmonary arterial hypertension due to congenital heart disease (PAH-CHD) with temporary shunt inversion and deoxygenation
Hohmann, Christopher
Dumitrescu, Daniel
Gerhardt, Felix
Kramer, Tilmann
Rosenkranz, Stephan
Huntgeburth, Michael
PULMONARY CIRCULATION, 2019, 9 (02)
[26] Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies
Chin, Kelly M.
Channick, Richard
Kim, Nick H.
Ong, Rose
Turricchia, Stefano
Martin, Nicolas
Mitchell, Lada
Mclaughlin, Vallerie V.
CARDIOLOGY AND THERAPY, 2024, 13 (04) : 775 - 796
[27] A Retrospective Comparison of Pulmonary Arterial Hypertension (PAH) Patients with Myositis-Related Autoantibodies to Patients with Idiopathic PAH and PAH Associated with Systemic Sclerosis
Si, S.
Weinmann, S.
McEvoy, C.
Chakinala, M. M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[28] Treatment and survival in patients with pulmonary arterial hypertension (PAH)
Kremers, Hilal Maradit
Slusser, Joshua P.
Scott, Christopher G.
Primatesta, Paola
McGoon, Michael D.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S25 - S25
[29] Lung transplantation in pulmonary arterial hypertension (PAH): survival analysis according to PAH risk
Ortega, M. Zapata
Lopez, E. Revilla
Gimenez, B. Saez
Garcia, C. Berastegui
Peris, M. Arjona
Torres, V. Monforte
Masgoret, C. Bravo
Ribas, E. Domingo
Meseguer, M. Lopez
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[30] Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
Zuckerman W.A.
Krishnan U.
Rosenzweig E.B.
Current Pediatrics Reports, 2013, 1 (2) : 92 - 101

← 1 2 3 4 5 →